Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›CCRP Initiative: Promoting a Basic Understanding of…

U.S. National Institutes of Health·United States of America

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028$300kGrants Notice
Get bids like this by emailBid source

Description

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Allergy and Infectious Diseases (NIAID) are soliciting applications to investigate the pathological mechanisms of skin injuries caused by toxic Chemicals of Concern (CoC) identified as public health threats by the United States Government. The goal of this initiative is to support the discovery and early development of broad-spectrum medical countermeasures (MCMs) to advance the nation's medical and public health preparedness for, response to, and recovery from high consequence chemical disasters and emergencies. * The initiative will focus on understanding the commonalities in the fundamental mechanisms of skin injuries caused by vesicants such as sulfur mustard, Lewisite, nitrogen mustard, phosgene oxime, arsenicals, and other toxic chemicals. * Responsive applications will investigate the molecular and cellular pathology of at least two chemicals, belonging to different toxidromes. * The initiative is part of a NIH-wide initiative to develop MCM to treat patients in mass casualty events after acute exposure to toxic chemicals as part of the Chemical Countermeasure Research Program (CCRP). * Applicants are encouraged to consider applying for this new funding opportunity, and team science approaches will be encouraged.

Attached files

Contact

Peter J Koch(Scientific/Research Contact)

[email protected]

(240) 987-8325

Key dates

Opened
6/30/2025
Closes
11/5/2028
Projected award
7/5/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-27-075

Budget estimate

$300,000

The Award Ceiling is explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 93%

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. National Institutes of Health·United States of America

87% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. National Institutes of Health·United States of America

85% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

82% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

82% match

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Closes 1/4/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

81% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

81% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. National Institutes of Health·United States of America

81% match

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases

Closes 3/3/2027Opened 6/10/2026

U.S. National Institutes of Health·United States of America

81% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

U.S. Food and Drug Administration·United States of America

81% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

80% match

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 12/12/2023

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

80% match

DoW Toxic Exposures Investigator Initiated Research Award

Closes 11/19/2026Opened 5/7/2026

U.S. National Institutes of Health·United States of America

80% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Science Foundation·United States of America

80% match

Division of Chemistry: Disciplinary Research Programs (CHE-DRP)

Rolling / TBD closeOpened 4/26/2023

U.S. National Institutes of Health·United States of America

79% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

79% match

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 9/29/2025

U.S. National Institutes of Health·United States of America

79% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

79% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

79% match

NIOSH Exploratory/Developmental Grant Program (R21)

Closes 11/21/2031Opened 7/27/2026

U.S. National Institutes of Health·United States of America

79% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Department Of Defense·Maryland

79% match

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Closes 5/1/2036Opened 4/23/2026

U.S. National Institutes of Health·United States of America

79% match

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Closes 10/25/2027Opened 1/15/2025

U.S. Food and Drug Administration·United States of America

79% match

Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

79% match

HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)

Closes 1/26/2027Opened 7/17/2025

U.S. National Institutes of Health·United States of America

78% match

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024